LABS LIADE BECOMES BOOTS PHARMA

The UK concern the Boots Company has changed the name of its subsidiary in Spain, Laboratorios Liade, to Boots Pharmaceuticals, in keeping with the company strategy to reinforce its name throughout Europe.

Boots acquired a 50% stake in the Spanish company in 1979 and then acquired the remaining 50% in 1981. Its product range includes the anti-infective Baccidal (norfloxacin), anti-arthritic agents Forben (flubiprofen and Neobrufen (ibuprofen) and the anti-ulcerant Ranix (ranitidine hydrochloride).